长沙招聘

JOB PURPOSE:
The role within the Sanofi Business Services (SBS) Region ASIA JPAC department owns and drives the Purchase-to-Pay (P2P) Process and Transformation Management with the guidance of the Head of the P2PSBS ASIA JPAC. The role is essentially that of a Country Project Lead.
He / she will be accountable to implement transformation projects for the Purchase-to-Pay (P2P) end-to-end processes for the SBS China.
P2P is an end-to-end process that consolidates the following processes & activities: Purchasing Operations, Vendor Master Data Management, Accounts Payable and Contract Management. It also includes Travel & Expenses.
He / she will closely collaborate with Regional Process Project Leads, external 3rd parties and other Sanofi / SBS internal stakeholders in the country.
ORGANIZATIONAL CONTEXT:
(See Organizational chart attached)
SBS is a new global and regional organization implemented in 2017 with the support of the Head of Purchase-to-Pay Process Management – Region ASIA JPAC
Effective change management required to manage transition from current operating models to future SBS P2P operating model
Overall business flexibility and agility is an expected must in order to accommodate for dynamic prioritization of tasks, and re-allocation of resource
SUPERVISED RESOURCES:
No subordinates
KEY ACCOUNTABILITIES:
Process Management
Define & manage the P2P end-to-end processes on a country level: responsible for alignment and consistency with the global core model and the detailed harmonization (mainly process levels 4
-6) of processes across the SBS China (aligned with global/ regional / local operational process requirements)
Support the Regional Project Lead in implementing standard processes and solutions, as well as process improvement initiatives with a specific focus on robotics and digitalization.
Ensure prioritization in line with resource requirements and availability on a country level, as well as with Global P2P priorities
Transformation Management
Identify, address and align necessary innovations and transformation initiatives as part of the P2P End-to-End process to regional roadmap.
Ensure together with the Regional Project Lead that key P2P projects deliver the expected benefits for the region in terms of efficiency, cost and quality, and timely delivery
Contribute to change management within the country
职位要求：
JOB-HOLDER ENTRY REQUIREMENTS:
Experience & knowledge:
-Excellent understanding of end-to-end Purchase-to-Pay processes
-Excellent program and project management skills (Ability to identify problems and define solutions incl. implementation plans in a structured manner)
-Track record of having effectively managed large projects (preferably within P2P) with a multitude of different work streams across multiple countries
-Track record in driving and managing process standardization.
-Experience in working in a Global Business Services environment is a plus
-International background with exposure to multicultural environments is a plus
Core competencies:
-Personality with strong management and delivery skills, focused on results / high levels of proactivity
-Ability to identify problems and define solutions incl. implementation plans in a structured manner
-Ability to drive change, and instill change of mindset
-Very good communicator with an ability to discuss on senior executive level within Sanofi SBS and outside of SBS China.
-Six Sigma LEAN certification is a plus
-Relevant certification in project/ program management is a plus
-Fluent in English (written and spoken)

赛诺菲集团
赛诺菲集团是一家全球领先的多元化医药健康企业，专注于患者需求，传播健康。
 全球100,000余名员工，业务遍及100个国家
 新兴市场实力均衡，表现强劲，位列***
 多元领域，覆盖处方药、健康药业产品、疫苗和动物保健品
 疫苗领域的领导者
 领先动物保健市场
 2011年集团净销售额达334亿欧元

赛诺菲在中国
赛诺菲是首批在中国开设办事处的跨国制药集团，也是国内增长最快的医药健康企业之一。目前，赛诺菲在中国200多个城市拥有6000余名员工。
   
传承悠久历史、持续开拓进取
赛诺菲一直以来秉承对中国的承诺。1982年，赛诺菲成为首批在中国开设办事处的跨国制药企业之一。今天，赛诺菲已跻身中国医药健康市场的领军企业。赛诺菲的中国总部位于上海，并在北京、天津、沈阳、济南、上海、杭州、南京、武汉、成都、广州和乌鲁木齐共设11家区域办公室。

独特的医药健康产品系列、满足中国公共卫生需求
从预防到治疗，赛诺菲全方位满足中国的公共健康需求。集团的疫苗事业部赛诺菲巴斯德是中国领先的疫苗企业。赛诺菲在心血管/血栓、糖尿病、肿瘤、内科和中枢神经系统等关键的治疗领域拥有领先产品。2010年，杭州赛诺菲民生健康药业有限公司的成立标志着赛诺菲进入中国的非处方药市场。2011年2月，赛诺菲完成了对BMP太阳石的收购。

大幅投资工业建设、满足中国市场需求
赛诺菲目前在中国拥有六家生产基地，包括北京制药工厂、杭州制药工厂、杭州赛诺菲民生健康药业工厂、南昌梅里亚动物保健工厂、深圳赛诺菲巴斯德疫苗工厂、以及唐山健康药业工厂。

完善的研发架构、双赢的研发合作模式
在中国，赛诺菲具有从药物靶点发现到后期临床研究的整体研发实力。集团在上海设有中国研发中心和亚太研发中心，并在北京和成都分别设有研发机构。自2008年以来，赛诺菲与中国权威科研机构开展了10多项战略合作，在癌症、干细胞、糖尿病和老年疾病等前沿研究领域探索创新药物

依托于强劲的研发能力和多领域领先水平的广泛的医药产品资源，公司在中国的市场份额不断攀升，公司规模不断扩大，飞速发展的业务给了我们与更多优秀人才合作的机会。

如需了解更多信息，请访问*************


现在就行动！把握机遇，加入我们，您的职业生涯将与赛诺菲共同成长！抓住机会，来亲身体验我们所秉持的胆略、创新、团结、勇气的价值观。

请将您的中英文简历发给我们，并在email标题栏注明您所申请的职位名称。每个职位申请一次即可，请不要重复投递简历。谢谢！